Latest News and Press Releases

LYON, France, June 14, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Prof. Gil Dubernard, Head of the Gynecology...

LYON, France, June 6, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that three oral presentations will be delivered on its...

First quarter 2022 revenue of approximately EUR 13.0 million (USD 14.5 million), an increase of 26% as compared to EUR 10.3 million (USD 12.4 million) for the first quarter 2021Four Focal One units...

Company to host conference call and webcast on, Wednesday, May 18th at 8:30 am EDT LYON, France, May 10, 2022 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies,...

  AUA is the largest annual gathering of urologists worldwide LYON, France, May 5, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies,...

  Company announces Focal One® placements at three renowned academic institutions in March LYON, France, April 12, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in...

Full year revenue of approximately EUR 44.1 million (USD 51.9 million) as compared to EUR 41.7 million (USD 47.8 million) for the full year 2020Full year US HIFU treatment volumes increased 65% over...

Company to host conference call and webcast on Thursday, March 31, at 8:30 am ET LYON, France, March 21, 2022 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today...

LYON, France, February 1, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today issued the following letter to shareholders: To my...

Represents first step towards a potential clinical treatment of locally advanced pancreatic cancer LYON, France, January 13, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global...